FDA Submits Information Collection for OMB Review and Clearance

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, following a comment request regarding additional risks in direct-to-consumer prescription drug television advertisements.